Biocryst Pharmaceuticals (BCRX) Assets: 2010-2015
Historic Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $139.0 million.
- Biocryst Pharmaceuticals' Assets rose 1.34% to $139.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $139.0 million, marking a year-over-year increase of 1.34%. This contributed to the annual value of $136.9 million for FY2014, which is 180.10% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Assets stood at $139.0 million for Q3 2015, which was down 7.47% from $150.2 million recorded in Q2 2015.
- Biocryst Pharmaceuticals' 5-year Assets high stood at $150.2 million for Q2 2015, and its period low was $39.9 million during Q2 2013.
- Moreover, its 3-year median value for Assets was $129.9 million (2015), whereas its average is $97.0 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Assets slumped by 47.64% in 2013 and then skyrocketed by 255.68% in 2014.
- Over the past 5 years, Biocryst Pharmaceuticals' Assets (Quarterly) stood at $82.2 million in 2011, then crashed by 30.13% to $57.4 million in 2012, then dropped by 14.93% to $48.9 million in 2013, then soared by 180.10% to $136.9 million in 2014, then climbed by 1.34% to $139.0 million in 2015.
- Its Assets stands at $139.0 million for Q3 2015, versus $150.2 million for Q2 2015 and $129.9 million for Q1 2015.